Article Versions Notes

McCabe NH, Stevenson L, Scanlon E, Douglas R, Kennedy S, Keminer O, Windshügel B, Zisterer D, Kennedy RD, Blayney JK, et al. Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches. Cancers. 2022; 14(15):3726. https://doi.org/10.3390/cancers14153726

McCabe, Niamh H., Leanne Stevenson, Enya Scanlon, Rosalie Douglas, Susanna Kennedy, Oliver Keminer, Björn Windshügel, Daniela Zisterer, Richard D. Kennedy, Jaine K. Blayney, and et al. 2022. "Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches" Cancers 14, no. 15: 3726. https://doi.org/10.3390/cancers14153726

McCabe, N. H., Stevenson, L., Scanlon, E., Douglas, R., Kennedy, S., Keminer, O., Windshügel, B., Zisterer, D., Kennedy, R. D., Blayney, J. K., & Turkington, R. C. (2022). Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches. Cancers, 14(15), 3726. https://doi.org/10.3390/cancers14153726